Coronavirus Diseases (COVID-19)
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1.Positive result of COVID-19 infection less than 3 days by RT-PCR; 2.Age between 18-59 years; 3.Asymptomatic infection was diagnosed and medical observation was carried out at the centralized isolation treatment point; 4.can understand and provide informed consent; 5.Commit to follow the research procedures and cooperate in the implementation of the whole process research; 6.Able to communicate with the study team by phone, email or text.
Exclusion criteria
Exclusion criteria: 1.Patients with a history of nasal surgery, chronic sinusitis, or routine daily nasal flushing or nasal drug intervention; 2.Patients with thyroid diseases, respiratory diseases or other serious basic diseases; 3.Allergy to iodine; 4.Participation in another prospective COVID related research project(clinical trial) within 1 month; 5.Pregnant or breastfeeding women; 6.Pregnancy tests in serum or urine of women of childbearing age were positive; 7.Immunodeficiency patients (such as malignant tumor patients, organ or bone marrow transplant recipients, AIDS patients, and immunosuppressive drugs within 3 months); 8.Other patients considered unsuitable by the investigator to participate in this study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Viral Negative rate by PCR on the tenth day; | — |
Secondary
| Measure | Time frame |
|---|---|
| the days that viral convert negative;Changes of viral load in pharyngeal swab;clinical discomfort reported by patients: headache, cough, runny nose, chest pain, fever, muscle soreness / fatigue, diarrhea / nausea / vomiting, loss of taste / smell and other symptoms.; | — |
Countries
China
Contacts
Ruijin Hospital,Shanghai Jiaotong University school of medicine